PROCEPT BioRobotics Corporation (PRCT)

PROCEPT BioRobotics Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	224.5	136.19	75.01	34.47	7.72
Revenue Growth (YoY)	64.84%	81.55%	117.60%	346.72%	25.09%
Cost of Revenue	87.4	65.14	37.93	18.61	8.97
Gross Profit	137.1	71.05	37.09	15.87	-1.26
Selling, General & Admin	171.42	131.77	88.83	51.04	30.27
Research & Development	62.3	48.45	28.98	18.99	16.28
Operating Expenses	233.71	180.22	117.81	70.03	46.55
Operating Income	-96.61	-109.17	-80.72	-54.16	-47.8
Interest Expense	-4.18	-4	-5.18	-5.81	-5.26
Interest & Investment Income	10.9	7.55	2.5	0.08	0.18
Other Non Operating Income (Expenses)	-1.51	-0.28	-0.49	0.05	-0.14
EBT Excluding Unusual Items	-91.41	-105.9	-83.9	-59.85	-53.02
Other Unusual Items	-	-	-3.26	-	-
Pretax Income	-91.41	-105.9	-87.15	-59.85	-53.02
Net Income	-91.41	-105.9	-87.15	-59.85	-53.02
Net Income to Common	-91.41	-105.9	-87.15	-59.85	-53.02
Shares Outstanding (Basic)	52	47	44	16	4
Shares Outstanding (Diluted)	52	47	44	16	4
Shares Change (YoY)	10.31%	6.43%	169.42%	349.90%	65.90%
EPS (Basic)	-1.75	-2.24	-1.96	-3.63	-14.47
EPS (Diluted)	-1.75	-2.24	-1.96	-3.63	-14.47
Free Cash Flow	-103.62	-133.21	-83.04	-57.93	-48.58
Free Cash Flow Per Share	-1.99	-2.82	-1.87	-3.52	-13.26
Gross Margin	61.07%	52.17%	49.44%	46.02%	-16.26%
Operating Margin	-43.04%	-80.16%	-107.61%	-157.12%	-619.44%
Profit Margin	-40.72%	-77.76%	-116.18%	-173.62%	-687.04%
Free Cash Flow Margin	-46.16%	-97.81%	-110.69%	-168.03%	-629.47%
EBITDA	-91.38	-105.36	-77.88	-50.84	-44.94
EBITDA Margin	-40.70%	-77.36%	-103.82%	-147.48%	-
D&A For EBITDA	5.23	3.81	2.84	3.32	2.86
EBIT	-96.61	-109.17	-80.72	-54.16	-47.8
EBIT Margin	-43.04%	-80.16%	-107.61%	-157.12%	-
Advertising Expenses	0.5	0.3	0.1	0.1	-

Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q